Skip to content
10-Q

Quarterly Report

Applied BioSciences Corp.

0001477932-19-004761

← back to feed
Filed
Aug 14, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Aug 7, 2019 13.45M sh
Operating Cash Flow Q1 2020 · Jun 30, 2019 −$399.04K
Operating Cash Flow Q1 2020 · Jun 30, 2018 −$162.04K
Stockholders Equity Q1 2020 · Jun 30, 2019 $1.79M
Stockholders Equity Q1 2020 · Mar 31, 2019 $2.13M
Stockholders Equity Q1 2020 · Jun 30, 2018 $648.32K
Stockholders Equity restated Q1 2020 · Mar 31, 2018 −$2.9M
Current Liabilities Q1 2020 · Jun 30, 2019 $674.67K
Current Liabilities Q1 2020 · Mar 31, 2019 $374.27K
Current Assets Q1 2020 · Jun 30, 2019 $239.57K
Current Assets Q1 2020 · Mar 31, 2019 $354.46K
Total Assets Q1 2020 · Jun 30, 2019 $3.52M
Total Assets Q1 2020 · Mar 31, 2019 $3.65M
Sga Expense Q1 2020 · Jun 30, 2019 $444.05K
Sga Expense Q1 2020 · Jun 30, 2018 $207.15K
Net Income Q1 2020 · Jun 30, 2019 −$507.93K
Net Income Q1 2020 · Jun 30, 2018 −$401.76K
Operating Income Q1 2020 · Jun 30, 2019 −$481.76K
Operating Income Q1 2020 · Jun 30, 2018 −$558.81K
Gross Profit Q1 2020 · Jun 30, 2019 $111.66K
Gross Profit Q1 2020 · Jun 30, 2018 −$7.32K
Cost Of Revenue Q1 2020 · Jun 30, 2019 $99.8K
Cost Of Revenue Q1 2020 · Jun 30, 2018 $17.76K
Revenue Q1 2020 · Jun 30, 2019 $211.46K
Revenue Q1 2020 · Jun 30, 2018 $10.43K